SUZANNE MAGANN: Open Payments
NPI 1841575768 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,087 in 119 payments from 16 companies in 2025. Trend: 2023 $1,559 · 2024 $1,656 · 2025 $2,087
Food & beverage: $2,068Education: $19
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $442 |
| ABBVIE INC. | 24 | $388 |
| UCB, Inc. | 8 | $202 |
| PFIZER INC. | 20 | $175 |
| Organon LLC | 6 | $144 |
| Novartis Pharmaceuticals Corporation | 7 | $135 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $110 |
| Arcutis Biotherapeutics, Inc. | 6 | $104 |
| Lilly USA, LLC | 4 | $72 |
| Incyte Corporation | 3 | $69 |
Products named: TREMFYA, SKYRIZI, Bimzelx, CIBINQO, RINVOQ, COSENTYX, HADLIMA, Zoryve.
Industry payments across WA — which companies pay providers there.
